Searchable abstracts of presentations at key conferences in endocrinology

ea0063p870 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Successful percutaneous radiofrequency ablation of a secreting juxtaglomerular cell tumour

Barraud Sara , Merzeau Nicolas , Diallo Alpha , Job Louis , Delemer Brigitte

Introduction: Juxtaglomerular cell tumour (JCT) or Reninoma, is a rare cause of curable secondary hypertension, usually presented as a small renal tumour and treated by tumorectomy or partial nephrectomy (PN). Minimally invasive treatment such as percutaneous radiofrequency ablation (PRFA) has gained popularity over the last decade to treat small tumors. We report the case of a woman with secondary hypertension due to JCT, successfully treated with PRFA....

ea0063p1104 | Pituitary and Neuroendocrinology 3 | ECE2019

Prevalence and study of neuroendocrine deficits in a series of 75 patients following traumatic brain injury

Daniel Sara , Bonneville Jean-Francois , Beckers Albert , Valdes-Socin Hernan

Introduction: Clinical research studies over the last 15 years have reported a significant burden of hypopituitarism in survivors of traumatic brain injury (TBI). However, these endocrine anomalies remain underdiagnosed.Patients and methods: We are studying data from a series of 75 TBI patients. They had a basal hormonal test, and dynamic confirmation tests if necessary. Somatotropic deficiency was defined by growth hormone (GH) remaining under 3 μg...

ea0063p1184 | Thyroid 3 | ECE2019

Screening of thyroid dysfunction in diabetic pregnant women

Atraki Sara , El Aziz Siham , Bensbaa Selma , Chadli Asmaa

Introduction: Thyroid disorders are quite common during pregnancy complicated by diabetes mellitus.Objective: The aim of our study was to detect thyroid disorders in a group of diabetic pregnant women.Patients and methods: Rétrospective study involving 243 pregnant women with diabetes followed in consultation or hospitalized in Endocrinology and Diabetology department of Ibn Rochd University Hospital of Casablanca, over a peri...

ea0063ep52 | Diabetes, Obesity and Metabolism | ECE2019

Penitentiary: diabetes and metabolic risk

Oukit Loubna , Askaoui Sara , El Mghari Ghizlane , El Ansari Nawal

Introduction: The prison environment is a space that involves some restrictions. However, diabetic patients require special attention. The aim of this work is to evaluate the impact of this area on the glycemic control and the metabolic profile.Patients and method: Descriptive cross-sectional study carried out on a day of health campaign in a penitentiary center, in the sector for men, and concerned the 62 known diabetic patients of the institution.<...

ea0063ep55 | Diabetes, Obesity and Metabolism | ECE2019

Münchhausen syndrome: in the light of 4 observations

Askaoui Sara , Lmghari Guizlane , Rafi Sana , El Ansari Nawal

Definition: Fake hypoglycaemia in children and adults is due to self-administration of insulin or insulin secretagogue. They represent one of the best described facets of the Münchhausen syndrome. Here we report four cases of false hypoglycemia following insulin injection.Material and method: Prospective study that took place over 2 years to collect 4 hospitalized cases for etiological assessment of severe hypoglycaemia up to 0.2 g/l and complicated...

ea0049ep772 | Clinical case reports - Thyroid/Others | ECE2017

Immune checkpoint inhibitors related thyroiditis – a report of two cases

Donato Sara , Antunes Pedro , Simoes-Pereira Joana , Simoes Helder

Introduction: Immune checkpoint inhibitors (ICPIs) are recent approved drugs used in malignant melanoma, non-small-cell lung cancer and renal cell cancer. They act by activating host T cell against malignant antigens. Immune checkpoint blockade can lead to breaking of immune self-tolerance, thereby inducing autoimmune/autoinflammatory side effects, such as endocrinopathies. It may affect thyroid, adrenal and pituitary. We present two ICPIs induced thyroiditis cases.<p clas...

ea0049ep783 | Endocrine Disruptors | ECE2017

Endocrine dysfunctions associated with Hodgkin Lymphoma treatment

Dias Daniela , Simoes-Pereira Joana , Donato Sara , Pereira Conceicao

Introduction: Hodgkin lymphoma (HL) survivors may develop a range of long-term complications that arise years after therapy. Among these, the endocrine dysfunctions are a major concern. Aim: To investigate the long-term endocrine effects of HL treatment.Methods: Revision of the HL patients’ medical files who were followed at our Endocrine Late-effects Clinics.Results: We studied 178 patients (86 (48.3%) were female), whose mea...

ea0049ep788 | Endocrine tumours and neoplasia | ECE2017

Endocrine health problems detected in 764 patients evaluated in a late effects clinic

Pereira Conceicao , Pereira Joana , Dias Daniela , Donato Sara , Salgado Dauarte

Context: Many pediatric cancer survivors have endocrine conditions. After alkylating agents, steroids, methotrexate and radiation, several endocrine dysfunctions may appear. Surveillance for late effects is recommended by worldwide guidelines.Objective: The objective of the study was to describe the endocrine outcomes of 764 patients followed during a 20 years period in our out-patient clinic.Design: The design was a retrospective ...

ea0049ep1142 | Female Reproduction | ECE2017

How far is possible to make a diagnosis of infertility

Dias Daniela , Simoes-Pereira Joana , Donato Sara , Pereira Conceicao

Introduction: Chemotherapy may be an important cause of primary infertility, especially in girls submitted to this therapy at very young ages.Clinical case: A 20-year-old female was diagnosed with acute lymphoblastic leukaemia at the age of 1. She was submitted to chemotherapy: intrathecal methotrexate and cyclophosphamide and i.v. doxorubicin, vincristine, mercaptopurine, asparaginase and bone marrow transplantation at the age of 2. She was ref...

ea0046p16 | (1) | UKINETS2016

Knockdown of Gα15 in BON cell line enhances pancreastatin inhibitory effect on neoplastic proliferation

Zanini Sara , Barron Gemma , Ahmed Irfan , Bermano Giovanna , Giovinazzo Francesco

Although initially considered rare, the incidence of pancreatic neuroendocrine tumours (P-NETs) has progressively increased. A population-based study conducted in England and Wales (1986–1999) found that 5-year survival was 29% for non-functioning and 41% for functioning tumours when considering well-differentiated P-NETs. Traditional treatments show very limited effectiveness; novel targeted therapies are, therefore, required and identification of key molecules driving n...